Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naofumi Takemoto

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Cutting edge: the differential involvement of the N-finger of GATA-3 in chromatin remodeling and transactivation during Th2 developmentNaofumi Takemoto, Ken-ichi Arai, Shoichiro Miyatake
The EMBO Journal|October 1, 2003
Hypomorphic mutation in an essential cell-cycle kinase causes growth retardation and impaired spermatogenesisJung Min Kim, Naofumi Takemoto, Ken-ichi Arai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiationNaofumi Takemoto, Andrew M Intlekofer, John T Northrup, et al.
The Journal of Experimental Medicine|August 19, 2007
Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cellsAndrew M Intlekofer, Naofumi Takemoto, Charlly Kao, et al.
International Journal of Clinical Oncology|October 31, 2003
C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effectiveTakuya Matsunaga, Katsuhisa Kogawa, Akihito Fujimi, et al.
Science (New York, N.Y.)|July 19, 2008
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesoderminAndrew M Intlekofer, Arnob Banerjee, Naofumi Takemoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2020
FXR mediates T cell-intrinsic responses to reduced feeding during infectionClarissa Campbell, Francois Marchildon, Anthony J Michaels, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 2, 2003
[Successful treatment with G-CSF and corticosteroid of adult idiopathic autoimmune neutropenia presenting as recurrent enterocolitis]Akihito Fujimi, Takuya Matsunaga, Rika Ohnishi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 5, 2002
[Treatment of chronic myelogenous leukemia with imatinib mesylate resulting in hematological remission and marked regression of myelofibrosis]Daisuke Takahari, Takuya Matsunaga, Akihito Fujimi, et al.
Nature Medicine|August 5, 2003
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemiaTakuya Matsunaga, Naofumi Takemoto, Tsutomu Sato, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Cutting edge: the differential involvement of the N-finger of GATA-3 in chromatin remodeling and transactivation during Th2 developmentNaofumi Takemoto, Ken-ichi Arai, Shoichiro Miyatake
The EMBO Journal|October 1, 2003
Hypomorphic mutation in an essential cell-cycle kinase causes growth retardation and impaired spermatogenesisJung Min Kim, Naofumi Takemoto, Ken-ichi Arai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiationNaofumi Takemoto, Andrew M Intlekofer, John T Northrup, et al.
The Journal of Experimental Medicine|August 19, 2007
Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cellsAndrew M Intlekofer, Naofumi Takemoto, Charlly Kao, et al.
International Journal of Clinical Oncology|October 31, 2003
C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effectiveTakuya Matsunaga, Katsuhisa Kogawa, Akihito Fujimi, et al.
Science (New York, N.Y.)|July 19, 2008
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesoderminAndrew M Intlekofer, Arnob Banerjee, Naofumi Takemoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2020
FXR mediates T cell-intrinsic responses to reduced feeding during infectionClarissa Campbell, Francois Marchildon, Anthony J Michaels, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 2, 2003
[Successful treatment with G-CSF and corticosteroid of adult idiopathic autoimmune neutropenia presenting as recurrent enterocolitis]Akihito Fujimi, Takuya Matsunaga, Rika Ohnishi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 5, 2002
[Treatment of chronic myelogenous leukemia with imatinib mesylate resulting in hematological remission and marked regression of myelofibrosis]Daisuke Takahari, Takuya Matsunaga, Akihito Fujimi, et al.
Nature Medicine|August 5, 2003
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemiaTakuya Matsunaga, Naofumi Takemoto, Tsutomu Sato, et al.
Pageof 2